Complement Factor C5a Mediates Renal Ischemia-Reperfusion Injury Independent from Neutrophils
- 1 April 2003
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 170 (7) , 3883-3889
- https://doi.org/10.4049/jimmunol.170.7.3883
Abstract
The complement system has been shown to mediate renal ischemia-reperfusion (I/R) injury. However, the contribution of complement factor C5a to I/R injury, in particular in the kidney, remains to be established. In this study, we investigated the impact of blocking the C5aR pathway on the inflammatory response and on the renal function in a murine model of I/R injury. First, we analyzed C5aR expression in kidneys of healthy mice. Intriguingly, we found expression on mesangial, as well as on tubular epithelial, cells. After I/R injury, C5aR expression was up-regulated in tubular epithelial cells. In addition, mRNA levels of CXC chemokines and TNF-α increased significantly and kidneys were heavily infiltrated by neutrophils. Blocking the C5aR pathway by a specific C5a receptor antagonist (C5aRA) abrogated up-regulation of CXC chemokines but not of TNF-α and reduced neutrophil infiltration by >50%. Moreover, application of the C5aRA significantly reduced loss of renal function. This improvement of function was independent of the presence of neutrophils because neutrophil depletion by mAb NIMP-R14 did not affect the protective effect of C5aRA treatment. Furthermore, blocking of the C5aR pathway had no influence on renal apoptosis. These data provide evidence that C5a is crucially involved in the pathogenesis of renal I/R injury by modulation of neutrophil-dependent as well as neutrophil-independent pathways, which include the regulation of CXC chemokines but not TNF-α or apoptotic pathways.Keywords
This publication has 40 references indexed in Scilit:
- Inhibition of complement factor C5 protects against renal ischemia-reperfusion injury: inhibition of late apoptosis and inflammation1Transplantation, 2003
- The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trialsBlood, 2002
- Enhanced expression of complement C5a receptor mRNA in human diseased kidney assessed by in situ hybridizationKidney International, 2001
- Predominant role for C5b-9 in renal ischemia/reperfusion injuryJournal of Clinical Investigation, 2000
- Neutrophils and renal failureAmerican Journal of Kidney Diseases, 1999
- Synergistic Enhancement of Chemokine Generation and Lung Injury by C5a or the Membrane Attack Complex of ComplementThe American Journal of Pathology, 1999
- Chemokines: Function, Regulation and Alteration of Inflammatory ResponsesPublished by S. Karger AG ,1999
- CorrectionHepatology, 1998
- Chemokine involvement in hepatic ischemia/reperfusion injury in mice: Roles for macrophage inflammatory protein-2 and KCHepatology, 1998
- Soluble Human Complement Receptor Type 1: In Vivo Inhibitor of Complement Suppressing Post-Ischemic Myocardial Inflammation and NecrosisScience, 1990